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Objectives. This study attempted to document the incidence of
pulmonary vein complications and their potential relation to
clinical outcome in patients after lung transplantation .
Background. Several case reports have documented the pres-
ence of pulmonary venous thrombosis causing graft failure in
patients after lung transplantation . Because the presentation of
these complications mimics that of other postoperative problems,
the true incidence of pulmonary vein abnormalities remains
unclear. Transesophageal echocardiography is ideally suited to
examine the pulmonary veins in the postoperative setting .
Methods. Twenty-one consecutive patients undergoing lung
transplantation at our institution underwent transesophageal
echocardiography within 32 days of transplantation (mean [±SDJ
6.5 ± 7.8 days) . Special attention was placed on visualizing the
pulmonary veins.
Lung transplantation is increasingly utilized as a treatment
modality for end-stage lung disease in patients refractory to
medical therapy. The actuarial survival rate at 1 year has been
reported to be as high as 86% with current surgical techniques
(1,2). Although survival rates continue to improve, many
patients continue to develop postoperative complications, such
as infection, acute rejection or ischemic reperfusion injury
(3-5) . There have been several case reports (6-10) of compli-
cations involving the pulmonary veins, most commonly second-
ary to occlusive thrombus at the anastomotic site . The true
incidence of these complications and their clinical significance
remain unknown because their clinical presentation can mimic
other, better recognized, problems . In most cases, pulmonary
venous thrombi have been diagnosed by transesophageal echo-
cardiography, which is ideally suited for the examination of the
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Results. Six (29%) of the 21 patients were noted to have
abnormalities of the pulmonary veins in the vicinity of the
anastomotic site. After follow-up of 30 days, 4 of these pa-
tients (67%) had significant cardiovascular morbidity, and 2 died,
compared with 1 (7%) of 15 patients with normal pulmonary veins
(p
®
0.03). The degree of obstruction of the pulmonary vein
appeared to correlate with short-term outcome .
Conclusions. Abnormalities of the pulmonary veins are com-
mon after lung transplantation and are easily identified by
transesophageal echocardiography. Occlusive thrombi appear to
be detrimental to short-term outcome .
(J Am Coll Cardiol 1994
;24:671-S)
pulmonary veins in the period after transplantation. The
procedure involves minimal risk to the patient, can easily be
performed at the bedside in the intensive care unit setting and
allows clear visualization of the pulmonary veins in most cases
(11,12) . Therefore, this prospective study was performed to
assess the incidence of complications involving the pulmonary
veins using transesophageal echocardiography and to investi-
gate their possible implications for short-term clinical out-
come .
Methods
Patients. Twenty-three patients underwent lung transplan-
tation at our institution from December 1992 to September
1993. Two patients were excluded because of failure to obtain
consent for transesophageal echocardiography, leaving 21 pa-
tients (14 women, 7 men ; mean [t SD] age 44 .8 t 13 .1 years)
who were included in this study. There were 16 single-lung, 4
double-lung and 1 heart-lung transplant recipients. The indi-
cations for transplant were chronic obstructive pulmonary
disease in 14 patients, cystic fibrosis in 3, primary pulmonary
hypertension in 2 and idiopathic pulmonary fibrosis and Eisen-
menger's syndrome in I each .
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JACC Vol . 24, No . 3
PULMONARY VEIN COMPLICATIONS AFTER LUNG TRANSPLANTATION
September 1994: 67 1
-5
672
LEtBOwrrz ET AL.
Table 1
. Characteristics of Patients With Pulmonary Venous Complications
CF = cystic fibrous; CHD -
congenital heart disease ; COPD = chronic obstructive pulmonary disease; D = double ; F = female; IPF = idiopathic pulmonary
Abrosir; L
-
left ; LUPV (RUPV) = left (right) upper pulmonary vein
; M = male ; NA = not applicable (external compression) ; PPH = primary pulmonary
hypertension
; Pt = patient ; PVT = pulmonary vein thrombus
; R - right; RLPV = right lower pulmonary vein ; TEE = transesophageal echocardiography; Tx =
trWAPlantation.
SerOcal tscbaigde. Single- or double-lung transplantation
was performed in all patients according to standard operative
techniques utilized at Columbia-Presbyterian Medical Center
in >100 lung transplantation procedures. The venous anasto-
moses were performed as follows. The donor lung was excised
by dividing the trachea, the pulmonary artery and the left
atrium so that a cuff of left atrium remained attached to the
donor lung. Once the recipient native lung was removed, a
clamp was placed on the left atrium proximal to the pulmonary
venous stumps, and an incision was made to join the pulmo-
nary veins and create a recipient atrial cuff . The donor lung was
then positioned in the thorax, and the donor and recipient
atrial cuffs were anastomosed.
Traasesapltgeal
echocardiography.
All 21 patients under-
went biplane transesophageal echocardiography at a mean of
63 ± 7.8 days after transplantation (range 0 to 32). Trans-
esophageal echocardiographic studies were performed using a
5.0-MHz biplane transesophageal probe (Hewlett-Packard
Sonos 1000). Imaging of the pulmonary veins was performed in
both the transverse and longitudinal planes. Color flow Dopp.
ler interrogation of the pulmonary veins was also performed
and, in two cases where occlusive thrombus was noted, pulsed
wave Doppler analysis of pulmonary venous flow was per-
formed as well. Images were recorded on 0.5-in . VHS video-
tape for later analysis .
Allah. Abnormalities of the pulmonary veins were diag-
nosed by the consensus of two experienced echocardiographers
(M.D.T., S.H.). A thrombus was defined as an echogenic mass
adherent to the wall of the pulmonary vein with either inde-
pendet., motion or different echo density . The maximal dimen-
sion of any thrombi found and the residual lumen diameter
were measured in the direction perpendicular to the lumen
wall using software incorporated into the ultrasound equip-
ment Mortality and morbidity data at 30-day follow-up after
transplantation were available for all patients from the routine
follow-up performed in the outpatient transplant clinic . Data
are expressed as mean value t SD. Comparison between the
proportions of patients with and without pulmonary vein
complications
was performed using the chi-square test, re-
placed by the Fisher exact test when the expected cell count
was less than five. A two-tailed p value <0.05 was considered
significant .
Results
In the 21 patients studied, a total of 63 pulmonary veins
were visualized. The right upper and lower as well as the left
upper pulmonary veins were consistently well visualized . The
left lower pulmonary vein was not well seen in most studies.
The right pulmonary artery anastomosis was well visualized in
9 (69%) of 13 cases and appeared normal in all . The left
pulmonary artery anastomosis was not well seen in most
studies. Abnormalities of the pulmonary vein were seen in six
patients (29%). Five patients had pulmonary vein thrombosis,
and one patient had external compression of a pulmonary vein
(Table 1). By 30 days after transplantation, two of these
patients had died, and two others had significant clinical
deterioration, as described later . Therefore, 4 (67%) of 6
patients with an abnormality of the pulmonary veins experi-
enced clinical deterioration at the time that such abnormalities
were documented by transesophageal echocardiography com-
pared with only 1(7%) of 15 patients with a normal study (p =
0.03) (Table 2). Among the 15 patients (72%) with patent
pulmonary veins, 1 patient died of multiorgan failure shortly
after transplant. Thirteen patients were alive and well at a
mean follow-up of 5 .3 t 2.6 months (range 1 to 6), and one
patient died of viral pneumonia 3 months after transplantation .
Although our numbers were small, the patients with pul-
monary vein thrombosis who died had a larger thrombi size
(mean 1.65 vs . 0.62 cm) and a smaller residual lumen (0 .42 vs .
0.93 cm) than the patients who survived . Pulsed wave Doppler
was performed in the two patients with nearly occlusive
thrombi. In Patient 1, a maximal gradient of 8 mm Hg across
the obstruction was noted, and in Patient 2, a maximal gradient
of 12 mm Hg was noted. In addition, color flow Doppler
interrogation in these patients revealed a turbulent color jet
across the obstruction, confirming the pulsed wave findings .
No significant differences were detected in patients with or
Pt NojGender
Age
(yr)
Indication
Site of
Lung Tx
Time to TEE
(days)
Location
of PVT
Width of
PVT
(cm)
Residual
Lumen
Diameter
(cm) Outcome
OF
34 IPF
L 9 LUPV
1 .7
0
.47 Died day l1
2/M 51
COPD R
Same day RUPV 1 .6 0.38 Died day 5
3/F
66 COPD L
3
RLPV
LUPV
Occlusive
0.6
None
1 .2 Alive at 5 mo
41M 31 CF
D 1 LUPV 0
.44
0.71 Alive at 5 mo
51F 59
PPH R 8
RUPV 0.82 0.88 Alive at I mo
61F
27 CHD R 23
RUPV NA 0.0 Alive at 4 mo
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Table 2 . Comparison of Patient ; With and Without Pulmonary
Venous Abnormality
Data presented are mean value t SD or number
('t)
of patients. I'reop
PAP = preoperative pulnwnary artery pressure; other at brevialions as in
Table I .
without pulmonary venous complications with regard to demo-
graphics or indications for transplantation (Table 2) . Intraop-
eratively, no particular problems performing the venous or
arterial anastamoses were noted in the patients who later
developed venous complications, and there were no intraop-
erative periods of hypotension or low flow states . In the two
patients with pulmonary venous thrombosis who underwent
reoperation, no technical problems with the anastomoses were
noted on direct visualization . Of the five patients with pulmo-
nary venous thrombosis who underwent transbronchial biopsy
(Patient I died before biopsy was performed), one (20%) had
at least mild acute rejection . Four (27%) of the 15 patients
without pulmonary venous thrombus had at least mild acute
rejection on biopsy (p = NS) . Therefore, the presence of
pulmonary venous complications did not seem to be correlated
with the presence of graft rejection .
Clinical history . Patient I initially had an uneventful post-
operative course but on day 9 suffered cardiac arrest . Emer-
gent transesophageal echocardiography revealed a large
thrombus along the insertion of the left upper pulmonary vein
into the left atrium (Fig. I, top). The patient underwent
emergency median sternotomy to evacuate the thrombus, and
repeat transesophageal echocardiography done after the pro-
cedure revealed a far smaller amount of thrombus with no
significant obstruction to flow (Fig . 1, bottom) . Despite these
efforts, the patient died shortly thereafter .
Patient 2 was noted to have decreasing oxygenation and
cardiac output several hours after his transplant . Emergent
transesophageal echocardiography revealed pulmonary vein
thrombosis in both right-sided pulmonary veins, and emer-
gency thrombectomy was performed . Repeat transesophageal
echocardiography done 3 days after removal of the pulmonary
vein thrombus confirmed the patency of the pulmonary veins .
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Figure 1 . Top, A nearly occlusive pulmonary vein thrombus (PVT) in
the left upper pulmonary vein (PV) of Patient I . Bottom, Repeat
examination after surgical thromhectomy showing patent pulmonary
vein . LA = left atrium .
However, the patient died 5 days after transplantation of
multiorgan failure .
Patients 3 and 4 had initially uneventful postoperative
courses, and pulmonary vein thrombosis was documented by
routine transesophageal echocardiography . The thrombi of
these two patients were substantially smaller than those in
Patients I and 2 . Both patients are alive at 5-month follow-up .
Patient 5 underwent single-lung transplantation and repair
of an atrial septal defect . Initial transesophageal echocardiog-
raphy done I day after transplantation showed patent pulmo-
nary veins . The patient did well for several days but noted mild
dyspnea thereafter. Chest X-ray film revealed increased right-
sided interstitial markings, and repeat transesophageal echo-
cardiography on day 8 after transplantation showed a throm-
bus in the right upper pulmonary vein .
In addition to the five patients who had pulmonary vein
thrombosis, a sixth patient who underwent heart-lung trans-
plantation for congenital heart disease and secondary pulmo-
nary hypertension underwent transesophageal echocardiogra-
phy in the setting of persistent hypoxemia despite mechanical
ventilation and extracorporeal membrane oxygenation . Chest
PVA Present
(n = 6)
PVA Absent
(n = 15)
P
Value
Age (yr) 44,8 ± 12.6 44.7 ± I6 .6
NS
M/F 2/4 51111 NS
COPD 2(33%) 12(8()%)
NS
PPH I (17%) ](7%) NS
IPF I (17%)
(I NS
CHD I (17"/;) 0 NS
CF
I (17°ri)
2(14%) NS
Preop PAP (mm Hg)
Systolic 54.6 ± 33.1 42.6 ± 31 .1 NS
Diastolic
23
.6 ± 16.11
19.7 ± 15 .6 NS
Lung Tx sue
Right
3(5(1%) 5 (33'ii) NS
Left
2 (33%)
7 (47%x)
NS
Double I (I7% ) 3 (20%) NS
Complications 4 (67%) I (7% )
0.03
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Figure 2. Top, Smooth tapering of the right upper pulmonary vein
(PV) secondary to external compression, Bottom, Same patient after
thoracotomy and evacuation of hematoma. The pulmonary vein is now
widely patent. LA = left atrium.
X-ray film at the time revealed a right-sided interstitial infil-
trate, and an open-lung biopsy showed focal alveolar damage
with septal edema . Transesophageal echocardiography visual-
ized external compression of the right upper pulmonary vein
with complete obstruction of flow (Fig. 2, top) . The patient
subsequently underwent thoracotomy with evacuation of 1 .5
liters of hematoma and subsequently had a rapid clinical
improvement. Follow-up transesophageal echocardiography
performed 2 weeks later confirmed patency of the previously
compressed pulmonary vein (Fig. 2, bottom).
Discussion
Incidence of pulmonary venous complications . Our results
suggest that complications involving the pulmonary veins after
lung transplantation may be more common than previously
suspected. In our series, 6 (29%) of 21 patients had abnormal-
ities of the pulmonary veins after lung transplantation . In the
only other published series, Hausmann et al . (6) reported one
pulmonary vein thrombus of 10 patients studied by transesoph-
ageal echocardiography (10%). The higher incidence in our
study may be related to earlier performance of the transesoph-
ageal echocardiography study because patients in the Haus-
mann et al. series were studied as late as 11 months after
transplantation . Another possible explanation is the use of a
biplane transesophageal echocardiographic probe in all pa-
tients in our series . Patients in our series were studied pro-
spectively and consecutively to provide an unbiased estimation
of the incidence of these complications . The clinical presenta-
tion of a pulmorar venous abnormality, namely, hypoxemia
and interstitial infiltrate in the transplanted lung, mimics other
potential postoperative complications, such as infection, graft
rejection and reperfusion injury (3-5) . Given our results, it is
important to consider such abnormalities as part of the differ-
ential diagnosis in patients presenting with hypoxia and pul-
monary infiltrates after lung transplantation. Moreover, be-
cause we were unable to consistently visualize the left lower
pulmonary vein, the actual incidence of pulmonary venous
complications may be even higher than our results indicate .
Predisposing factors. It remains unclear what factors may
predispose patients to develop pulmonary venous thrombosis .
Standard surgical technique was performed in all patients, with
no particular problems in any patient . As noted, no clinical
variable could be identified that was associated with these
complications. Only standard preoperative coagulation evalu-
ation, (i .e ., prothrombin and partial thromboplastin times) was
performed, so we cannot definitely rule out an occult hyper-
coagulable state in the patients with pulmonary venous throm-
bosis. However, none of these patients had an antecedent or
family history of thrombotic events, making this an unlikely
explanation for these findings .
Safety of transesophageal echocardiography. There were
no complications related to the use of transesophageal echo-
cardiography in this series, confirming the safety of the proce-
dure in these patients. Moreover, the accuracy of transesoph-
ageal echocardiography in detecting pulmonary venous
complications was confirmed in the three patients who under-
went reoperation .
Clinical Implications of finding a pulmonary venous compli-
cation. Although our overall numbers were too small to show a
significant mortality difference in patients with and without pul-
monary venous abnormalities, a significant difference between the
groups with regard to 30-day morbidity was evident . The relation
between these abnormalities and poor outcome (i .e., whether
they are a cause for graft failure and death or whether they form
as a result of graft failure) remains unclear, as do the long-term
prognostic implications of the development of a
pulmonary
vein
abnormality. The clarification of this relation would be of obvious
importance for planning possible therapeutic interventions.
Schmid et al . (7) reported the successful use of recombinant tissue
plasminogen activator to lyse a pulmonary vein thrombus that
extended into the left atrium in a patient with graft failure after
lung transplantation. The patient's clinical condition subsequently
improved, a finding that supports the concept that pulmonary
vein obstruction may have important clinical consequences of its
own. However, two patients in our series who had pulmonary vein
thrombosis in the setting of clinical deterioration and underwent
surgical removal of the thrombus died despite this intervention .
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Although this may argue against pulmonary vein thrombosis as a
primary cause of graft failure, it is possible that surgical interven-
tion was performed too late for any chance of graft recovery . A
third patient with pulmonary vein thrombosis improved clinically
after the initiation of anticoagulation . Our other two patients with
pulmonary vein thrombosis had no apparent clinical sequelae .
These differences in clinical outcome maybe related to the size c f
the thrombus. Both patients with large thrombi and small residual
lumen diameters as well as evidence of obstruction to flow by
color Doppler died, whereas those patients with smaller, nonob-
structive thrombi had no apparent clinical sequelae . These find-
ings seem to suggest that small, nonobstructive thrombi may be
managed conservatively, but larger ones may require interven-
tion. Further investigation is necessary to determine which pa-
tients may benefit from the therapeutic intervention, such as
anticoagulaticri or thrombectomy, as well as the possible role of
routine pcrioperativc anticoagulation .
Conclusions. The results of our study indicate that abnor-
malities of the pulmonary veins after lung transplantation may
he more common than previously suspected . Transesophageal
echocardiography is an ideal method with which to evaluate
the pulmonary venous anastomotic sites in patients after lung
transplantation, particularly if the patient is in clinically unsta-
ble condition . In addition, the finding of a pulmonary venous
abnormality may he associated with poor short-term outcome,
particularly if it causes significant obstruction to blood flow.
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